DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy Assessment of Two Antibiotic Prophylaxis Regimens in Oral and Maxillofacial Trauma Surgery

Information source: Universidade Federal do Rio Grande do Norte
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Facial Fractures

Intervention: Cefazolin (Procedure); Cefazolin Single Dose (Procedure)

Phase: Phase 2

Status: Recruiting

Sponsored by: Universidade Federal do Rio Grande do Norte

Official(s) and/or principal investigator(s):
Adriano Germano, PhD, Study Chair, Affiliation: Universidade Federal do Rio Grande do Norte

Summary

The study set out to evaluate the efficacy of two antibiotic prophylaxis regimens in patients with facial fractures admitted to the Oral and Maxillofacial Surgery and Traumatology services of the Onofre Lopes University Hospital attached to the Federal University of Rio Grande do Norte.

Clinical Details

Official title: Efficacy Assessment of Two Antibiotic Prophylaxis Regimens in Oral and Maxillofacial Trauma Surgery.

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Primary outcome: Reduction of postoperative infection

Detailed description: The study set out to evaluate the efficacy of two antibiotic prophylaxis regimens in patients with facial fractures admitted to the Oral and Maxillofacial Surgery and Traumatology services of the Onofre Lopes University Hospital attached to the Federal University of Rio Grande do Norte. This clinical study was prospective, randomized and controlled. Patients underwent surgery for facial fracture reduction and fixation under general anesthetic. Prior to surgery, patients were randomly divided into two groups. Group

1 patients each received 2g of Cefazolin (Cefazolin Sodium - Ampoule- 1g - Genéricos

Brasil), administered intravenously but none was administered in the post-operative period. Group II patients received the same dose prior to the operation but in the post-operative period they also received 4 additional 1 g doses of Cefazolin intravenously, completing a 24 period of antibiotic prophylaxis. In the case of operations that lasted for more than 4 hours, an additional 1g dose was given. The surgical operations involved intra and extra-oral interventions and when required internal rigid fixation was undertaken using titanium plates and screws. Patients were given advice on oral hygiene procedures to be followed in the post-operative period that included chlorhexidine (0. 12%) oral rinses and care to be taken with the surgical wounds. Post-operative follow up was conducted in the 1st, 2nd, 4th and 6th weeks. The criteria used to determine the presence of infection were: a) pus drainage at the fracture site or in the vicinity of the surgical intervention site; b) increased swelling 7 days after the operation; c) presence of a fistula in the area of the surgical intervention or at the site of the fracture, with active drainage; d) other clinical features observed by the evaluator including typical signs of infection such as fever, edema, and localized redness. Descriptive analysis was made of the independent variables, namely, age, sex, presence of systemic diseases, trauma cause, drug use (tobacco, alcohol, marijuana, crack, cocaine , etc.), the time lapse between the trauma event and the surgical operation, length of the operation, and the measures adopted when infections were detected.

Eligibility

Minimum age: 15 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Both genders

- ASA I, II, III

- have facial fractures, that request surgical treatement, and whitout infection

Exclusion Criteria:

- Patients with pan-facial fractures

- Or requiring surgery longer than six hours

Locations and Contacts

Oral and Maxillofacial Surgery and Traumatology services of the Onofre Lopes University Hospital, Natal, Rio Grande do Norte 59012-300, Brazil; Recruiting
Giordano Campos, DDS, Phone: +558491015536, Email: giordano_campos@hotmail.com
Adriano Germano, PhD, Principal Investigator
Giordano Campos, DDS, Sub-Investigator
Additional Information

Full project.

Starting date: December 2011
Last updated: November 18, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017